Finance

Beta
Lists
BLISSGVS:NSE
Bliss GVS Pharma Ltd
₹523.20
-0.18%
(-0.95) 1D
Jul 10, 11:21:58 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BLISSGVS...
Open
₹525.00
High
₹535.45
Low
₹520.50
Mkt. cap
55.11B
Avg. vol.
1.43M
Volume
75.10K
Dividend
0.29%
Quarterly dividend
₹0.37
Ex-dividend date
Jul 8, 2026
P/E ratio
43.60
52-wk high
₹553.00
52-wk low
₹118.00
EPS
₹12.00
Shares outstanding
103.15M
No. of employees
1K
Open
₹525.00
High
₹535.45
Low
₹520.50
Mkt. cap
55.11B
Avg. vol.
1.43M
Volume
75.10K
Dividend
0.29%
Quarterly dividend
₹0.37
Ex-dividend date
Jul 8, 2026
P/E ratio
43.60
52-wk high
₹553.00
52-wk low
₹118.00
EPS
₹12.00
Shares outstanding
103.15M
No. of employees
1K
News stories
From sources across the web
About Bliss GVS Pharma Ltd
CEO-
Employees1.03K
Founded1984
Headquarters-
SectorPharmaceutical industry
Websiteblissgvs.com
Last report
May 12, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
2.57B / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.07B
2.44B
2.18B
2.57B
Cost of goods sold
918.92M
1.18B
1.02B
1.36B
Cost of revenue
918.92M
1.18B
1.02B
1.36B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
310.03M
333.51M
359.36M
1.00B
Operating expense
824.49M
1.03B
901.49M
844.80M
Total operating expenses
1.74B
2.21B
1.92B
2.21B
Operating income
331.28M
234.96M
264.40M
363.12M
Other non operating income
354.54M
201.78M
184.56M
-597.23M
EBT including unusual items
631.11M
406.33M
408.96M
449.50M
EBT excluding unusual items
631.11M
406.33M
434.09M
431.08M
Income tax expense
187.50M
120.44M
161.17M
79.51M
Effective tax rate
29.71%
29.64%
39.41%
17.69%
Other operating expenses
432.45M
612.37M
458.64M
-244.91M
Net income
430.38M
272.50M
232.66M
355.75M
Net profit margin
20.74%
11.15%
10.66%
13.84%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
167.47M
Interest expense
-54.72M
-30.42M
-14.86M
-20.08M
Net interest expenses
-54.72M
-30.42M
-14.86M
147.40M
Depreciation and amortization charges
82.01M
82.62M
83.50M
86.71M
EBITDA
393.75M
317.28M
326.86M
431.12M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer